All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Immune comparison

LL-37 vs Thymosin α-1

An educational, source-based comparison of LL-37 and Thymosin α-1 — how each peptide works, what it's researched for, and what to know before going deeper.

Immune · Antimicrobial
LL-37

Human cathelicidin peptide with antimicrobial and immune-modulating activity.

Mechanism

The only human cathelicidin antimicrobial peptide. Research demonstrates broad antimicrobial activity against bacteria, viruses, and fungi, plus immunomodulatory effects on neutrophils, macrophages, and wound healing.

Research areas
  • Chronic biofilm infections
  • Wound healing and dermatology
  • Innate immune modulation
Considerations
  • Not FDA-approved.
  • Pro-inflammatory effects possible at higher doses.
Full LL-37 profile →
Immune Modulation
Thymosin α-1

Studied in immune modulation and resilience contexts.

Mechanism

A 28-amino-acid peptide naturally produced by the thymus. Research indicates it modulates T-cell maturation, dendritic cell function, and innate immune signaling. Approved in several countries (under the name Zadaxin) as an adjunct in hepatitis B/C and certain cancer protocols.

Research areas
  • Chronic viral hepatitis (approved use abroad)
  • Vaccine response augmentation
  • Immunosenescence
  • Adjunct in oncology research
Considerations
  • Approved in 35+ countries but not FDA-approved in the US.
  • Generally well tolerated in published clinical data.
  • Requires physician oversight.
Full Thymosin α-1 profile →

LL-37 vs Thymosin α-1 — Key differences

  • Class: LL-37 is classified as Immune · Antimicrobial, while Thymosin α-1 is Immune Modulation.
  • Primary research focus: LL-37chronic biofilm infections; Thymosin α-1chronic viral hepatitis (approved use abroad).
  • Tag: Immune · Antimicrobial vs Immune.

Related comparisons